Tamoxifen + exemestane preferred in early breast cancer

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.495, 2006-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Experience with Exemestane in the Treatment of Early and Advanced Breast Cancer

By Lønning Per Eystein   Geisler Jürgen  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 987-997

Informa Healthcare

Access to resources Recommend Favorite

Switch to exemestane beneficial in early breast cancer

By  

Inpharma, Vol. 1, Iss. 1617, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Switch to exemestane beneficial in early breast cancer

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 543, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Switching to adjuvant exemestane after tamoxifen improves disease-free survival in postmenopausal women with hormone receptor-positive early breast cancer

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 5, 2007-05 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Exemestane in postmenopausal women with early or advanced breast cancer: a review

By Bertelli Gianfilippo   Gangadhara Sharath  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1933-1942

Informa Healthcare

Access to resources Recommend Favorite